|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0770 EUR | -3.02% |
|
+4.76% | +18.10% |
| Mar. 09 | TME Pharma Secures 12-month Loan Extension | MT |
| Jan. 05 | TME Pharma N.V. Provides Update on Its Activities | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 8.61M | - | - | - | - | - |
| 43.38B | |||||
| 31.64B | |||||
| 30.26B | |||||
| 27.35B | |||||
| 18.84B | - | - | - | - | - |
- Stock Market
- Equities
- ALTME Stock
- Charts TME Pharma N.V.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
